Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | RNK05047 |
| Trade Name | |
| Synonyms | RNK-05047|RNK 05047 |
| Drug Descriptions |
RNK05047 is a BRD4-chaperone-mediated protein degrader (BRD4-CHAMP), which binds to BRD4 and targets it for degradation via interaction with HSP90, potentially resulting in antitumor activity (European Journal of Cancer 174 (2022): S27). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C189823 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| RNK05047 | RNK05047 | 0 | 1 |